- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00793260
Deep Dive Randomized Control Trial
Study Overview
Status
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Maine
-
Portland, Maine, United States, 04101
- Health Dialog Analytic Solutions, Inc
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- All employees, dependents and retirees in one of seven large employer groups, including a state university system, a state employee group, two manufacturing companies, a natural resource extraction company, a public educational service agency, and a nonprofit multiple employer association for independent colleges were eligible for inclusion.
Exclusion Criteria:
- no financial information was available from their facility and professional claims;
- they were in an employer sub-group ineligible for care support services;
- they asked not be to contacted or were deceased;
- gender information was missing from their eligibility files;
- their claims data from the year prior to the start of the study indicated diagnoses of HIV, AIDS, end-stage renal disease (ESRD), organ transplants, or necrotizing fasciitis (intended to improve the likelihood of a balanced distribution of costs and conditions); OR
- they were in an employer sub-group with less than four months of enrollment prior to the study start date (resulting in too little information for stratification).
Study Plan
How is the study designed?
Design Details
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Usual Support Group
Predictive models in the Usual-Support Group were aimed at identifying individuals through medical claims and administrative data (such as hospitalization notification).
The output of the predictive models is a rank-ordered, or stratified, list of individuals who have support needs.
These lists were then used to generate outbound mail, interactive voice response (IVR) calls or calls by health coaches.
|
Predictive models in the Usual-Support Group were aimed at identifying individuals through medical claims and administrative data (such as hospitalization notification).
The output of the predictive models is a rank-ordered, or stratified, list of individuals who have support needs.
These lists were then used to generate outbound mail, interactive voice response (IVR) calls or calls by health coaches.
|
Experimental: Enhanced Support Group
The Enhanced-Support Group intervention used more sophisticated predictive models, more extensive outreach to engage individuals, and provided tighter feedback loops to inform the care support process.
|
The Enhanced-Support Group program used lower risk thresholds for targeted outreach of individuals with chronic illness and for those likely to face discrete surgical interventions. Individuals at high financial risk but without one of the five chronic conditions were included in the Enhanced-Support Group. The Enhanced-Support Group received up to five initial reach attempts while the Usual-Support Group received up to three attempts. The Enhanced-Support Group used a 'tight loop' management structure including detailed, timely coach level feedback reports on efficiency and effectiveness. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
---|
The primary outcome measure was total medical costs (capped at $200,000 per individual per year) and pharmacy costs.
|
Secondary Outcome Measures
Outcome Measure |
---|
Secondary measures included utilization of selected services.
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: David E Wennberg, MD, MPH, Health Dialog
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- DeepDive
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Uterine Diseases
-
Albert Einstein College of MedicineNational Cancer Institute (NCI)TerminatedUterine Corpus Leiomyosarcoma | Stage IIA Uterine Sarcoma | Stage IIB Uterine Sarcoma | Stage IIIA Uterine Sarcoma | Stage IIIB Uterine Sarcoma | Stage IIIC Uterine Sarcoma | Stage IVA Uterine Sarcoma | Stage IVB Uterine Sarcoma | Stage IA Uterine Sarcoma | Stage IB Uterine Sarcoma | Stage IC Uterine SarcomaUnited States
-
University of AarhusRecruitingUterine Cervical Neoplasm | Mass Screening | Uterine Cervical Disease | Uterine NeoplasmDenmark
-
Albert Einstein College of MedicineNational Cancer Institute (NCI)TerminatedUterine Carcinosarcoma | Stage IIA Uterine Sarcoma | Stage IIB Uterine Sarcoma | Stage IIIA Uterine Sarcoma | Stage IIIB Uterine Sarcoma | Stage IIIC Uterine Sarcoma | Stage IVA Uterine Sarcoma | Stage IVB Uterine Sarcoma | Stage IA Uterine Sarcoma | Stage IB Uterine Sarcoma | Stage IC Uterine SarcomaUnited States
-
GlaxoSmithKlineCompletedCervical Cancer | Neoplasms, Uterine Cervix
-
Huazhong University of Science and TechnologyUnknownCervical Cancer | Uterine Cervical Cancer | Uterine Cervical NeoplasmChina
-
Huazhong University of Science and TechnologyChongqing University Cancer Hospital; Peking University People's Hospital; Qilu... and other collaboratorsRecruitingCervical Cancer | Uterine Cervical Cancer | Uterine Cervical NeoplasmChina
-
Hillel Yaffe Medical CenterUnknownUterine Neoplasms | Uterine Cervical NeoplasmIsrael
-
Centre Oscar LambretTerminatedUterine Cervical CancerFrance
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.RecruitingUterine Cervical CancerChina
-
Becton, Dickinson and CompanyTerminatedUterine Cervical NeoplasmUnited States, Canada
Clinical Trials on Usual-Support
-
University of PittsburghPenn State UniversityCompleted
-
Mayo ClinicNational Institute of Nursing Research (NINR)CompletedPalliative CareUnited States
-
Groupe Hospitalier Paris Saint JosephWithdrawn
-
University of California, San FranciscoCompleted
-
Norwegian University of Science and TechnologySt. Olavs HospitalCompleted
-
Tilburg UniversityInstitute Verbeeten Tilburg; ETZ TweeSteden Hospital TilburgActive, not recruitingMyocardial Infarction | Myocardial Ischemia | Autonomic DysfunctionNetherlands
-
Case Western Reserve UniversityNational Institute of Nursing Research (NINR); National Institutes of Health...CompletedCritical IllnessUnited States
-
Geisinger ClinicYale UniversityCompleted
-
University of Las Palmas de Gran CanariaServicio Canario de SaludCompleted